New fibromyalgia drug shows promise in Long-Term safety trial

NCT ID NCT07637162

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests the long-term safety and effectiveness of an experimental drug called AXS-14 for people with fibromyalgia, a condition causing widespread pain and fatigue. About 300 adults who previously took part in a related study will receive AXS-14 for 52 weeks. Researchers will monitor side effects to see if the drug is safe for extended use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibromyalgia Hyperalgesia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Research Site

    Arkansas City, Arkansas, 72211, United States

  • Clinical Research Site

    Redlands, California, 92374, United States

  • Clinical Research Site

    Sacramento, California, 95821, United States

  • Clinical Research Site

    Santa Ana, California, 92705, United States

  • Clinical Research Site

    Jacksonville, Florida, 32256, United States

  • Clinical Research Site

    Orlando, Florida, 32801, United States

  • Clinical Research Site

    Tampa, Florida, 33634, United States

  • Clinical Research Site

    Atlanta, Georgia, 30329, United States

  • Clinical Research Site

    Norcross, Georgia, 30092, United States

  • Clinical Research Site

    Chicago, Illinois, 60634, United States

  • Clinical Research Site

    Overland Park, Kansas, 66209, United States

  • Clinical Research Site

    Louisville, Kentucky, 40205, United States

  • Clinical Research Site

    Boston, Massachusetts, 02131, United States

  • Clinical Research Site

    Brooklyn, New York, 11235, United States

  • Clinical Research Site

    Tulsa, Oklahoma, 74133, United States

  • Clinical Research Site

    Charleston, South Carolina, 29407, United States

  • Clinical Research Site

    Knoxville, Tennessee, 37909, United States

  • Clinical Research Site

    Memphis, Tennessee, 38119, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.